Vimarsana
Biggest News Aggregation in the World

Static Physician News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Static Physician. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Static Physician Today - Breaking & Trending Today

EMA Approves Tx for Psoriasis and Other Autoimmune Disorders - Vimarsana News

EMA Approves Tx for Psoriasis and Other Autoimmune Disorders

The biosimilar Pyzchiva is highly similar to Stelara, which was approved in the EU in 2009.

Tapinarof Cream 1% Rapidly Improves Mild to Severe Plaque Psoriasis - Vimarsana News

Tapinarof Cream 1% Rapidly Improves Mild to Severe Plaque Psoriasis

Patients with plaque psoriasis, including in intertriginous areas and genitalia, experienced rapid improvement when treated with tapinarof cream 1%, offering an effective and well-tolerated nonsteroidal option for this condition.

Bruce E Strober, MD, PhD: Efficacy of Risankizumab for Treating Plaque Psoriasis - Vimarsana News

Bruce E Strober, MD, PhD: Efficacy of Risankizumab for Treating Plaque Psoriasis

Results of several clinical trials demonstrated the superior efficacy of risankizumab compared with apremilast or placebo.

Brodalumab for Psoriasis Shows Significant Improvement in Mental Health Symptoms - Vimarsana News

Brodalumab for Psoriasis Shows Significant Improvement in Mental Health Symptoms

This new research demonstrated that when TNF-inhibition is effective, a shift to brodalumab treatment may be useful in suppression of psoriasis and improvement of patients’ quality of life.

Risankizumab Significantly Reduces Severity of Plaque Psoriasis Compared to Apremilast - Vimarsana News

Risankizumab Significantly Reduces Severity of Plaque Psoriasis Compared to Apremilast

Patients on risankizumab also reported greater satisfaction with treatment for moderate plaque psoriasis.